Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

Abstract Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and oth...

Full description

Bibliographic Details
Main Authors:	Juan F. Reyes, Sara Ekmark-Léwen, Marina Perdiki, Therése Klingstedt, Alana Hoffmann, Emilia Wiechec, Per Nilsson, K. Peter R. Nilsson, Irina Alafuzoff, Martin Ingelsson, Martin Hallbeck
Format:	Article
Language:	English
Published:	BMC 2021-03-01
Series:	Acta Neuropathologica Communications
Online Access:	https://doi.org/10.1186/s40478-021-01136-3

Similar Items

Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
by: Agata Aniszewska, et al.
Published: (2022-07-01)

Alpha-synuclein oligomers - neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
by: Martin Ingelsson
Published: (2016-09-01)

Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
by: Gabriel Gustafsson, et al.
Published: (2017-12-01)

Luminescent conjugated oligothiophenes distinguish between α-synuclein assemblies of Parkinson’s disease and multiple system atrophy
by: Therése Klingstedt, et al.
Published: (2019-12-01)

Studies on alpha-synuclein and islet amyloid polypeptide interaction
by: Ye Wang, et al.
Published: (2023-01-01)

Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes.
by: Jakob Domert, et al.
Published: (2016-01-01)

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson’s disease
by: Daniel Kam Yin Chan, et al.
Published: (2017-12-01)

Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease
by: Bianca Vlcek, et al.
Published: (2023-10-01)

Alpha-Synuclein spreading in Parkinson disease
by: Ariadna eRecasens, et al.
Published: (2014-12-01)

Alpha-Synuclein Aggregation in Parkinson's Disease
by: E. Srinivasan, et al.
Published: (2021-10-01)

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease
by: Parkkinen, L, et al.
Published: (2003)

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia
by: Parkkinen, L, et al.
Published: (2004)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021-11-01)

Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
by: Mónica Gómez-Benito, et al.
Published: (2020-04-01)

Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms
by: Parkkinen, L, et al.
Published: (2007)

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
by: Javiera Arcos, et al.
Published: (2023-12-01)

Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease
by: Qian-Qian Chen, et al.
Published: (2018-06-01)

17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
by: Michael Riedel, et al.
Published: (2010-01-01)

Targeting alpha-synuclein as a therapy for Parkinson’s disease
by: Fields, CR, et al.
Published: (2019)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
by: Demetrius M. Maraganore
Published: (2011-05-01)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
by: Guoxin Zhang, et al.
Published: (2018-11-01)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
by: Emily Fitzgerald, et al.
Published: (2019-04-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
by: Puyu Li, et al.
Published: (2021-10-01)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
by: Shengli Xu, et al.
Published: (2015-06-01)

Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease
by: Serge Moudio, et al.
Published: (2022-02-01)

Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization.
by: Winny Ariesandi, et al.
Published: (2013-01-01)

Antibodies against alpha-synuclein reduce oligomerization in living cells.
by: Thomas Näsström, et al.
Published: (2011-01-01)

The role of alpha-synuclein oligomers in Parkinson's disease pathophysiology and biology
by: Roberts, R
Published: (2015)

The Role of Astrocytes and Alpha-Synuclein in Parkinson’s Disease: A Review
by: David Brash-Arias, et al.
Published: (2024-03-01)

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
by: Kamil Saramowicz, et al.
Published: (2023-12-01)

Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
by: Maxime Teixeira, et al.
Published: (2021-09-01)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
by: Sindhu Menon, et al.
Published: (2022-05-01)

Macroautophagy, alpha-synuclein and dopamine neurotransmission: implications for Parkinson’s disease
by: Hunn, BHM
Published: (2017)

Olfactory deficits in an alpha-synuclein fly model of Parkinson's disease.
by: Alex Y Chen, et al.
Published: (2014-01-01)

Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
by: Richard M. Meade, et al.
Published: (2019-07-01)

Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
by: Sara A. Ferreira, et al.
Published: (2018-08-01)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
by: Alice J. White, et al.
Published: (2018-11-01)

Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
by: Giorgio Vivacqua, et al.
Published: (2016-01-01)